Compare PRDO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRDO | BHVN |
|---|---|---|
| Founded | 1994 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1997 | 2022 |
| Metric | PRDO | BHVN |
|---|---|---|
| Price | $32.69 | $14.41 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $22.93 |
| AVG Volume (30 Days) | 441.0K | ★ 2.6M |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | 10.50 | ★ 26.08 |
| EPS | ★ 1.60 | N/A |
| Revenue | ★ $581,296,000.00 | N/A |
| Revenue This Year | $0.99 | N/A |
| Revenue Next Year | $2.98 | N/A |
| P/E Ratio | $21.17 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.66 | $7.48 |
| 52 Week High | $38.50 | $18.57 |
| Indicator | PRDO | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 48.14 | 59.31 |
| Support Level | $31.40 | $13.56 |
| Resistance Level | $32.98 | $15.27 |
| Average True Range (ATR) | 0.87 | 0.80 |
| MACD | 0.01 | 0.37 |
| Stochastic Oscillator | 31.31 | 60.36 |
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.